临床外科杂志 ›› 2022, Vol. 30 ›› Issue (12): 1159-1166.doi: 10.3969/j.issn.1005-6483.2022.12.018

• 论著 • 上一篇    下一篇

乳腺癌生存结果性别差异与肿瘤亚型的关系

  

  1. 430060 武汉大学人民医院麻醉科
  • 收稿日期:2022-01-22 接受日期:2022-01-22 出版日期:2022-12-20 发布日期:2023-01-20
  • 通讯作者: 李晶,Email:378401405@qq.com

Study of gender differences in breast cancer survival outcomes in relation to tumor subtypes

  1. Department of Anesthesiology,Renmin Hospital of Wuhan University,Hubei,Wuhan 430060, China
  • Received:2022-01-22 Accepted:2022-01-22 Online:2022-12-20 Published:2023-01-20

摘要: 目的 通过对男性乳腺癌和女性乳腺癌病人进行基于人群的最大规模的比较研究,探讨乳腺癌生存结果性别差异与肿瘤亚型的关系。方法 利用2010~2012年美国疾病监测、流行病学和最终结果(SEER)项目获得的数据,进行一项基于人群的回顾性队列研究,调查男性和女性在肿瘤亚型、总体生存率(OS)和乳腺癌特异性死亡率(BCSM)的差异。结果 181814例乳腺癌病人(男性1516例,女性180298例)符合本研究。男性病人多为黑人,年龄大,组织学分级较低、分期较晚,肿瘤直径较大,淋巴结和远处转移较多,人表皮生长因子受体2(HER2)阴性(P<0.05)。配对分析显示,男性和女性病人的2年OS分别为91.2%和93.7%,BCSM分别为2.2%和2.5%。单因素分析显示,男性三阴性(TN)、激素受体(HoR)阳性/HER2阳性和HoR阳性/HER2阴性病人的OS较差(P<0.01)。同时,HoR阳性/HER2阳性和TN亚型与男性病人的BCSM显著相关(P<0.01)。多因素分析显示,男性TNBC病人的OS和BCSM较差(P<0.05)。同时,结果显示,在调整其他因素后,HoR阳性/HER2阴性亚组中的男性病人死于BC的可能性较小(P<0.05)。结论 乳腺癌亚型的2年OS和BCSM分析显示,TN亚型的男性乳腺癌和女性乳腺癌病人有明显的差异。

关键词: 乳腺癌, 生存结果, 性别差异, 肿瘤亚型

Abstract: Objective Exploring the relationship between gender differences in breast cancer survival outcomes and tumor subtypes by conducting the largest population-based comparative study of men with breast cancer and women with breast cancer.Methods A population-based retrospective cohort study using data from the US disease surveillance,epidemiology and final outcomes(Seer) Project 2010-2012,to investigate differences in tumor subtypes,overall survival(OS),and breast cancer-specific mortality(BCSM) between men and women.〖WTHZ〗Results〓〖WTBZ〗A total of 181814 breast cancer patients(1516 men and 180298 women) met the criteria of this study.The male patients were mostly black people,old,with low histological grade,late stage,large tumor,more lymph node and distant metastasis,and human EGFR 2(HER2) negative tumor(P<0.05).The two year OS of male and female patients was 91.2% and 93.7%,and that of BCSM was 2.2% and 2.5%,respectively.Univariate analysis showed that the OS of male triple negative(TN),hormone receptor(Hor)/HER2 positive and HOR/HER2 negative patients were worse(P<0.01).At the same time,both HOR/HER2 positive and TN subtype were significantly associated with BCSM in male patients(P<0.01).Multivariate analysis showed that OS and BCSM were worse in patients with TN MBC(P<0.05).At the same time,the results showed that male patients in the HR +/HER2 negative subgroup were less likely to die of BC after adjustment for other factors(P<0.05).Conclusion A 2year OS and BCSM analysis of breast cancer subtypes showed significant differences between male and female breast cancer patients with TN subtypes,and these differences deserve further study.

Key words: breast cancer, survival outcome, sex difference, tumor subtype

[1] 金一 王昕仪 杜润森 郑丽华 赵亚恒 杨艳. 乳腺癌组织hsa-mir-337表达降低的临床意义与预后分析[J]. 临床外科杂志, 2022, 30(4): 345-348.
[2] 金成龙 张建国. 乳腺癌新辅助化疗后前哨淋巴结活检的研究进展[J]. 临床外科杂志, 2022, 30(4): 386-389.
[3] 曹思旸 刘霞 朱丽璋 刘晓岭 钟洁愉 孙德胜 韦伟. 吲哚菁绿联合亚甲蓝在早期乳腺癌前哨淋巴结活检中应用的荟萃分析[J]. 临床外科杂志, 2022, 30(3): 239-243.
[4] 袁泳锨 庾建中 王永霞. 乳腺癌细胞外泌体miR-27a对巨噬细胞极化及肿瘤生长和转移的影响[J]. 临床外科杂志, 2022, 30(2): 149-154.
[5] 马强 杨丽 何建信 张春霞 郝金燕. T1~2期人表皮生长因子受体2阳性型及非阳性型浸润性乳腺癌微钙化特点比较[J]. 临床外科杂志, 2022, 30(2): 156-159.
[6] 王庆. 乳腺骨肉瘤化生性癌一例[J]. 临床外科杂志, 2022, 30(12): 1118-1119.
[7] 杨建国 杨红利 王乐. 缺氧诱导因子1α联合c-myc预测三阴性乳腺癌病人术后生存[J]. 临床外科杂志, 2022, 30(12): 1172-1175.
[8] 毛艳 王海波. 2021.V5 NCCN 临床实践指南:乳腺癌新辅助治疗更新解读[J]. 临床外科杂志, 2022, 30(1): 23-26.
[9] 张明坤 王哲 杨柳 侯兰 张聚良. 黏液性乳腺癌的预后影响因素分析与预后模型构建[J]. 临床外科杂志, 2022, 30(1): 44-50.
[10] 周蓓 樊利春 吴沉昊 王婧. TSPAN13在乳腺癌组织中的表达及与临床病理特征的关系[J]. 临床外科杂志, 2021, 29(9): 834-837.
[11] 塔娜 王霞 李文娟 张爱红. 乳腺癌超声造影征象与高尔基磷酸化蛋白3表达的关系[J]. 临床外科杂志, 2021, 29(9): 838-841.
[12] 雷浩 杨文荣 李仲华. OCA2 基因核苷酸rs4778137多态性对三阴性乳腺癌新辅助化疗效果的影响研究[J]. 临床外科杂志, 2021, 29(9): 842-846.
[13] 梁烁 王聪 姚昶 许岩磊 赵倩馨. 浆细胞性乳腺炎合并浸润性导管癌误诊一例[J]. 临床外科杂志, 2021, 29(7): 690-692.
[14] 叶倩 闫朝岐. 三维超声对乳腺癌腋窝淋巴结状态的评估[J]. 临床外科杂志, 2021, 29(5): 499-500.
[15] 蔡耿喜 刘强. 乳腺癌的精准治疗[J]. 临床外科杂志, 2021, 29(3): 201-207.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 胡善彪;余少杰;彭龙开. 婴幼儿供肾移植[J]. 临床外科杂志, 2016, 24(10): 741 .
[2] 齐卫鹏;王剑明;刘颜;等. 术前应用靛氰绿检测联合三维重建成像评估肝门部胆管癌肝脏储备功能[J]. 临床外科杂志, 2016, 24(10): 756 .
[3] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[4] 刘琼;江辉. 喉罩在小儿舌系带矫正手术中的应用[J]. 临床外科杂志, 2016, 24(10): 792 .
[5] 余兰;聂秀. 脾脏硬化性血管瘤样结节性转化二例[J]. 临床外科杂志, 2016, 24(10): 808 .
[6] 涂儒鸿;黄昌明. 腹腔镜胃癌根治术淋巴结清扫技巧[J]. 临床外科杂志, 2016, 24(11): 809 .
[7] 曹志新. 基于膜解剖的胃癌D2手术[J]. 临床外科杂志, 2016, 24(11): 812 .
[8] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[9] 林伟箭;洪雪辉;许淑镇;等. 吸引器在腹腔镜胃癌根治术中的应用体会[J]. 临床外科杂志, 2016, 24(11): 824 .
[10] 吴川清;刘炜圳;帅晓明;等. 超声内镜在胃癌术前诊断中的应用分析[J]. 临床外科杂志, 2016, 24(11): 828 .